Joel H Rubenstein, MD, MSc, AGAF, FACG, FASGE

 Joel Rubenstein
Professor of Internal Medicine
Program Director, Fellowship - Advanced Esophageal
Medical School
Email:
[email protected]
Available to mentor
Joel H Rubenstein, MD, MSc, AGAF, FACG, FASGE
Joel Rubenstein
Professor
  • Center Memberships
  • Recent Publications

  • Manage Your Profile

    • Center Memberships
    • Center Member
      e-Health and Artificial Intelligence Initiative
    • Center Member
      Institute for Healthcare Policy and Innovation
    • Center Member
      Rogel Cancer Center

    Recent Publications

     See All Publications
    • Journal Article
      Greater Esophageal Cancer Burdens in Rural United States: A Surveillance, Epidemiology, and End Results Program Analysis.
      Gerber A, Yoon JY, Hur C, Rubenstein JH. Am J Gastroenterol, 2026 Aug 28; DOI:10.14309/ajg.0000000000004189
      PMID: 42669461
    • Journal Article
      Shared decision making in Eosinophilic esophagitis: Integrating physician and patient perspectives
      Ryan KA, Darpel KK, Rubenstein JH, Dellon ES, Wallner LP, De Vries R, Chang JW. PLOS One, 2026 Jun 10; 21 (6): e0350662 - e0350662. DOI:10.1371/journal.pone.0350662
    • Journal Article
      Mo1134 THE BOSS TRIAL WAS LIKELY UNDERPOWERED FOR ITS PRIMARY OUTCOME OF OVERALL MORTALITY REDUCTION: A MODELING STUDY
      Yoon JY, van den Berg DM, Lim F, Omidvari AH, Agyekum A, Inadomi JM, Curtius K, Lansdorp-Vogelaar I, Hur C, Rubenstein JH. Gastrointestinal Endoscopy, 2026 May 2; 103 (5): s - 780. DOI:10.1016/s0016-5107(26)02054-7
    • Journal Article
      Mo1134 THE BOSS TRIAL WAS LIKELY UNDERPOWERED FOR ITS PRIMARY OUTCOME OF OVERALL MORTALITY REDUCTION: A MODELING STUDY
      Yoon JY, van den Berg DM, Lim F, Omidvari AH, Agyekum A, Inadomi JM, Curtius K, Lansdorp-Vogelaar I, Hur C, Rubenstein JH. Gastroenterology, 2026 May 7; 170 (6): s - 780. DOI:10.1016/s0016-5085(26)02123-2
    • Proceeding / Abstract / Poster
      Tu1114 ALIGNMENT OF TREATMENT PREFERENCE ARCHETYPES AND REALWORLD OUTCOMES IN ADULT EOSINOPHILIC ESOPHAGITIS: WHERE ARE THEY NOW?
      Chang JW, Brophy K, Ryan KA, Rubenstein J, Wallner LP, Dellon ES. Gastroenterology, 2026 May 3; 170 (6): s - 823. DOI:10.1016/s0016-5085(26)02214-6
    • Proceeding / Abstract / Poster
      Tu1114 ALIGNMENT OF TREATMENT PREFERENCE ARCHETYPES AND REALWORLD OUTCOMES IN ADULT EOSINOPHILIC ESOPHAGITIS: WHERE ARE THEY NOW?
      Chang JW, Brophy K, Ryan KA, Rubenstein J, Wallner LP, Dellon ES. Gastrointestinal Endoscopy, 2026 May 6; 103 (5): s - 823. DOI:10.1016/s0016-5107(26)02145-0
    • Journal Article
      Adjunctive Use of p53 Immunohistochemistry for Risk Stratification in Barrett's Esophagus: A Systematic Review and Meta-Analysis.
      Sawas T, Davitkov P, Zhou M, Eluri S, Leiman DA, Thrift AP, Singh S, Inadomi J, Katzka D, Rubenstein JH, Stachler M, Wani S. Am J Gastroenterol, 2026 Feb 25; DOI:10.14309/ajg.0000000000003977
      PMID: 41738629
    • Journal Article
      AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus
      Wani S, Zhou MJ, Sawas T, Rubenstein JH, Eluri S, Leiman DA, Sultan S, Singh S, Inadomi J, Thrift AP, Katzka DA, Davitkov P. Gastroenterology, 2025 Nov 1; 169 (6): 1184 - 1231. DOI:10.1053/j.gastro.2025.09.012

    Featured News & Stories

         red cells clustered together inside body black light up blue see through
    Health Lab

    Understanding esophageal cancer

    In this Q&A, a Michigan Medicine doctor talks about esophageal cancer, its signs and risk factors to know.